Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

134
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
134
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
124

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Mycobacterium tuberculosis</i> subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.

iScience·2026
Same author

Longitudinal TCR repertoires in ulcerative colitis patients show features distinguishing disease states.

Inflammatory bowel diseases·2026
Same author

Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells.

Inflammatory bowel diseases·2026
Same author

Sex-Specific Differences in Outcomes and Trends in Patients With Ulcerative Colitis.

Gastro hep advances·2026
Same author

Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study.

Inflammatory bowel diseases·2025
Same author

An Integrated Large-Scale Atlas of Protein Quantitative Trait Loci across Olink and SomaScan platforms.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Jun 17, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.3K

Systematic Review: Outcome Prediction in Acute Severe Ulcerative Colitis.

Julia Angkeow1, Alissa Rothman2, Lara Chaaban1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Gastro Hep Advances
|August 12, 2024
PubMed
Summary

Predicting outcomes in acute severe ulcerative colitis (ASUC) is vital. This review identified key clinical, endoscopic, and radiographic predictors to personalize patient care and optimize therapy for ASUC exacerbations.

Keywords:
Acute Severe Ulcerative ColitisPredictors of OutcomeSystematic Review

More Related Videos

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K

Related Experiment Videos

Last Updated: Jun 17, 2025

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.3K
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Inflammatory Bowel Disease Research

Background:

  • Acute severe ulcerative colitis (ASUC) affects approximately 25% of ulcerative colitis patients, necessitating hospitalization.
  • Early prediction of ASUC outcomes is crucial for effective patient management and therapy optimization.

Purpose of the Study:

  • To systematically review and identify key predictors of outcomes in acute severe ulcerative colitis (ASUC).
  • To summarize evidence-based predictors for optimizing therapeutic strategies and advancing personalized patient care in ASUC.

Main Methods:

  • A systematic literature review was conducted using Embase and Medline databases (2000-2023).
  • Study screening and data extraction were performed by two independent reviewers using Covidence.
  • Quality appraisal of included studies utilized the Critical Appraisals Skills Program.

Main Results:

  • Forty-eight eligible studies were included in the review.
  • Key predictors identified encompass clinical, endoscopic, and radiographic biomarkers.
  • Outcomes assessed included intravenous corticosteroid failure, need for rescue therapy, and colectomy; score-based predictions and novel markers were also reported.

Conclusions:

  • Evidence-based predictors can personalize ASUC treatment and improve patient care.
  • Further research is needed to identify and validate additional clinical and laboratory predictors, particularly early in hospitalization.
  • Continuous evolution of predictive markers is essential as medical therapies advance.